The benzodiazepine antagonist flumazenil (0.01 mg/kg) has been compared with doxapram (1 mg/kg) and saline for the reversal of anaesthesia with intravenous midazolam, alfentanil, nitrous oxide in oxygen and isoflurane. The completeness of reversal was assessed by means of a four-choice reaction time test, 1 and 3 h following the antagonist. In addition, the level of sedation was graded using a five-point scale.
Introduction
Medullary stimulants and other drugs including naloxone', aminophyllineand physostigmine", have been used to antagonize the effects of midazolam. However, all are non-specific and results have been negative or equivocal. More recently Breimer and colleagues" have confirmed that physostigmine is ineffective against midazolam and causes serious haemodynamic side effects. Doxapram hydrochloride is principally a respiratory stimulant acting on the aortic and carotid chemoreceptors''. Extensive investigations have however shown that it has an arousal effect following non-benzodiazepine anaesthesia's? and diazepam", The specific benzodiazepine antagonist flumazenil is the product of many years of research following the identification of a specific benzodiazepine receptor", Several studies have now established that flumazenil can antagonize midazolam sedation 10 • ll but there is continuing concern about the completeness of reversal and the possibility of re-sedation particularly after large doses of agonist-'; Furthermore deaths have recently been reported in which re-sedation after flumazenil was cited as a contributory factor following overdoses of benzodiazepinea'<'".
To date, there have been only a few studies of the effectiveness offlumazenil in restoring psychomotor performance after large doses of benzodiazepine agonist, and none of these compared the effectiveness of other antagonists. Furthermore, other workers have concentrated on short-term clinical follow-up relying solely on subjective assessments of the degree of sedation. In a small study of gynaecological patients given midazolam, fentanyl and halothane, higher sedation scores were observed 2 h after flumazenil than in an untreated control group15. These findings were not supported by the four-choice reaction time results. It is difficult to see how flumazenil could actually produce worse sedation scores unless midazolam clearance was altered by the antagonist.
Another study'" using midazolarn/fentanyl for total intravenous anaesthesia also reports that re-sedation may occur 2 h after flumazenil. The re-bound potential of high-dose fentanyl is well-known and complicates interpretation of the findings. Clearly, there is a need for a well controlled study of the effectiveness of flumazenil in reversing the sedative and psychomotor effects of midazolam.
Choice reaction time tests are sensitive measures of drug-induced changes in psychomotor performance'". In a single reaction time test a visual or sensory stimulus requires a motor response, the latency of which is the reaction time. In a choice reaction time test, the element of choice offers a number of alternative responses and in this, a measure of attention as well as latency. Scott et al. 18 found the four-choice reaction time test to be a sensitive measure of the residual effects of anaesthetic drugs.
The present study was planned to investigate the reversal by flumazenil of the effects of a fixed intravenous dose ofmidazolam (0.3 mg/kg) at a fixed time (60 min) after the administration of the agonist. The patients were to be observed for 3 h after reversal, that is 4 h after the midazolam, to allow evidence of re-sedation to become apparent. A placebo injection and doxapram were included in the study on a doubleblind basis.
Method Following University Medical Research Ethical
Committee approval and informed patient consent, 60 unpremedicated patients who were aged 18-60 years, ASA grade I or II, were admitted to the study. Those who had significant cardiac, respiratory, hepatic or renal disease or who were taking benzodiazepine medication were excluded. All the patients were scheduled for arthroscopy or dilatation and curettage, lasting for less than 45 min.
Prior to surgery the patients were visited in the ward, where informed consent and baseline readings of the four-choice reaction time test were obtained. This was performed on a portable machine by the method described by Wilkinson and Houghton'", The test involved following, as quickly as possible, a random sequence of lights by pressing the corresponding button. Each subject was given a practice 
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median four-choice reaction times had returned to baseline levels in all groups. One patient in the saline group and three patients in the doxapram group were so drowsy that they were unable to perform the fourchoice reaction time test at one hour and were given high arbitrary values in Figure 1 . Though the sedation scores were assessed every 15 min from administration of the trial drug, analysis was confined to data obtained before, and at 15, 60, 120 and 180 min after reversal (Fig. 2) . The difference in the sedation scores between the saline and flumazenil groups was significant at 15 and 60 min (P< 0.001), at 120 min (P<O.Ol) and at 180 min (P<0.05).
Saline Doxapram Flumazenil 60
Time (min) Figure 1 . Four-choice reaction times in individual patients in whom reversal ofmidazolam sedation was attempted with [lumazenil, doxapram or saline. The assessment was made at the times shown before and after administration of the 'reversal' agent (time 0). The highest values with doxapram and saline are arbitrary for patients who were unable to perform the test at 60 min and the lines join the median values for each treatment run before performing the test twice for 2.5 min on two occasions. Two and a half minutes is thought to be the minimum time that is required to detect any loss of concentrating ability that may accompany sedation without being affected by boredom. The tests were recorded on a magnetic cassette tape and analysed by an Apple lIe computer on which a decoding programme had been loaded. The results obtained were the average reaction times for each test period.
In the anaesthetic room a 20G indwelling venous cannula was inserted and anaesthesia induced with alfentanil 0.25 mg followed one minute later by midazolam 0.3 mg/kg. Anaesthesia was maintained with 67% N 20 in O 2 and isoflurane 1%, the patient breathing spontaneously throughout. Arterial pressure, heart rate and ECG were monitored throughout the anaesthetic and in the recovery ward.
Following surgery, the patients were randomly allocated to receive one of the following: flumazenil 0.01 mg/kg, or doxapram 1 mg/kg, each made up to 10 ml with 0.9% sodium chloride, or 10 ml 0.9% sodium chloride, all being given intravenously over 5 min. The level of sedation was assessed by a 'blind' observer one hour after induction of anaesthesia, according to a 5-point scale.
Grade Level of sedation 1
Fully awake and orientated 2
Drowsy but does not fall asleep 3
Asleep, responds to verbal stimulation 4
Asleep, responds to painful stimuli 5
Unresponsive to painful stimuli The trial drug was then administered and the assessment of the level of sedation repeated at 15-min intervals for 3 h. All the assessments were carried out by one person. Four-choice reaction time tests were repeated one and three hours after the trial drug administration.
Statistical analyses were performed using Kruskal-Wallis and Mann-Whitney Utests; a Pvalue of <0.05 was considered significant.
Results
Twenty patients were studied in each group and were comparable as regards sex, age and weight ( Table 1) . The difference in the anaesthetic times between the control and the doxapram group was not significant. Similarly, there were no significant differences in the number of patients in the three groups undergoing dilatation and curettage, or arthroscopy. Figure 1 shows the scatter of four-choice reactions time for the three groups with the median values. The percentage changes are shown in Table 2 . At 60 min from administration there were significant differences between the percentage increase in the flumazenil group and those in the saline and doxapram groups (P< 0.05). However, by 3 h, the Between the doxapram and flumazenil groups there were significant differences at 15 min (P< 0.001) and 60 min (P< 0.01). There was no significant difference between the saline group and the doxapram groups.
There were no cardiovascular or other serious side effects following flumazenil administration. Three patients who received flumazenil experienced slight nausea and two became flushed, while one patient who received doxapram was nauseated.
Discussion
The investigation was designed to reduce to a minimum the sedative effects arising from drugs other than midazolam. Nitrous oxide and isoflurane both have very rapid washout times and the duration of action of alfentanil is extremely short (t\i=75-96 min).
The findings of this study show that flumazenil (0.01 mg/kg) reverses the clinical sedative effects of anaesthetic induction doses ofmidazolam. Overall, by 60 min after reversal, all the patients except one (doxapram) were either wide awake or easily roused verbally. At this stage, 14 of the flumazenil group were 'wide awake' compared to four and three in the doxapram and saline groups respectively. The findings, also at 60 min, that both the four-choice reaction times and sedation scores were increased in the nonflumazenil treated groups is unsurprising. More unexpected is the observation at 180 min, that although the four-choice reaction times had returned to baseline values, the sedation scores in the untreated saline group remained higher than in those who received flumazenil. This indicates that lightly sedated patients, when roused, are able to perform the test to their original preoperative standard, although their ability to sustain their attention is doubtful.
Other workers have stressed the danger of resedation 4.12 after large doses of midazolam followed by a single bolus offlumazenil. This could occur due to the short half-life of flumazenil (one hour)2o compared with that of midazolam (2-5 h)21. Clinical re-sedation did not, however, occur in the present study.
The dose offlumazenil used in the investigation was 0.01 mg/kg given over 5 min, which is less than the dosage used by some workers previously4. 22 . No stress effects attributable to acute benzodiazepine withdrawal, such as anxiety or hypertension were seen and other workers have confirmed the absence of any rise in plasma catecholamines or significant cardiovascular effects 23.24. There seems therefore little to be gained by reducing the dosage of flumazenil further and it is likely that the duration of action would be longer with higher doses.
Although there was no clinical re-sedation in this study with midazolam, continuous observation and monitoring of vital signs are essential when using intravenous benzodiazepines, whether or not flumazenil has been used.
